BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV Trademark
Trademark Overview
On Tuesday, March 5, 2024, a trademark application was filed for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV with the United States Patent and Trademark Office. The USPTO has given the BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark a serial number of 98433749. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 5, 2024. This trademark is owned by TG Therapeutics, Inc.. The BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing health information
General Information
| Serial Number | 98433749 |
| Word Mark | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV |
| Filing Date | Tuesday, March 5, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, March 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 0 - NOT AVAILABLE |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold. |
| Indication of Colors claimed | The color(s) black, dark grey, light blue and gold is/are claimed as a feature of the mark. |
| Goods and Services | Providing health information |
| NOT AVAILABLE | "150 MG/6ML INJECTION FOR IV" |
| Translation of Words in Mark | The wording BRIUMVI has no meaning in a foreign language. |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 5, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, December 28, 2022 |
| First Use In Commerce Date | Wednesday, December 28, 2022 |
Trademark Owner History
| Party Name | TG Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10014 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 5, 2024 | NEW APPLICATION ENTERED |
